Doctor's Notes

Dialkyl-Thiourea Allergy From Neoprene Taekwondo Shoes in One Athlete

Fictional editorial illustration for Dialkyl-Thiourea Allergy From Neoprene Taekwondo Shoes in One Athlete featuring Dr. Arsy #003

Doctor’s Notes · Life in Motion · Evidence Review

Editorial disclosure: The featured image is an AI-created illustration of a fictional activity or occupational setting. It is not a patient, diagnosis, before-and-after image, institutional endorsement or Dr. Arsy #003 treatment result.

Reader question: What did this exact paper measure, in whom, with which comparator and timepoint—and which conclusions would go beyond its evidence?

Study snapshot

Study element Reported detail
Population One 12-year-old boy with severe bilateral foot dermatitis and neoprene taekwondo-shoe exposure.
Design Case report with extended patch testing and exposure-history review.
Comparator Significant positive reaction to mixed dialkyl thioureas and exposure avoidance; no control athlete.
Timepoint At diagnosis and after avoidance; the abstract states resolution but not the exact interval.
Key result The exposure review identified neoprene taekwondo shoes as the likely source, and dermatitis resolved after allergen avoidance.
Funding/conflict context Funding and author conflicts were not stated in the PubMed abstract.

What was actually measured?

The exposure review identified neoprene taekwondo shoes as the likely source, and dermatitis resolved after allergen avoidance.

The improvement after removal is consistent with the patch-test finding but is not a randomized rechallenge.

The denominator defines the claim. A diagnostic case, a patch-test reaction, a material analysis and a population rate answer different questions. None should be silently converted into another.

What the result does not prove

A single pediatric case cannot estimate sport-wide incidence or prove that all neoprene footwear contains the same allergen.

Temporal or anatomic alignment can strengthen an exposure hypothesis, but it does not automatically prove individual causation. Referral patterns, prior sensitization, friction, sweat, occlusion, cleaning products, adhesives, metals, rubber additives and equipment age may all shape the finding.

A PubMed record is a bibliographic source. PubMed indexing is not NIH endorsement of the paper’s conclusions, this interpretation or any product.

Keep the condition categories separate

Dryness, friction injury, irritant dermatitis, allergic contact dermatitis, infection and swelling are not interchangeable. Patch testing evaluates delayed contact allergy; it does not diagnose every rash or replace clinician judgment.

Rapid facial or throat swelling, breathing difficulty, spreading redness, drainage, fever, severe pain, widespread blistering or loss of function requires prompt medical assessment. Do not deliberately re-expose yourself to suspected equipment or chemicals.

Activity and exposure details worth documenting

  • Exact equipment, surface, material, adhesive, cleaner, glove, shoe, strap or instrument touching the area.
  • Location and shape of the skin change relative to the contact site.
  • Time from exposure to symptoms, and what changed during rest or avoidance.
  • Sweat, friction, pressure, wetness, occlusion, ultraviolet exposure and cleaning routines.
  • Manufacturer material disclosures, workplace safety data and clinician-directed testing—not self-testing.

Prevention comes before cosmetic care

Prevention must match the hazard: fit and friction control, material substitution, protective equipment, engineering controls, occupational-health review and clinician-guided allergen avoidance. Never apply workplace or sports chemicals directly to skin to “test” them.

Primary research and authoritative guidance

Where Dr. Arsy #003 fits

Dr. Arsy #003 is a cosmetic moisturizer for hydration, moisture-barrier support and dry-skin comfort. This paper did not test #003. Its findings do not show that #003 treats, cures or prevents eczema, allergy, infection, blisters or swelling; relieves pain or itch; neutralizes an allergen; is appropriate for every person; or provides pediatric or 24-hour efficacy.

Continue the evidence series

Evidence note: This educational article separates reported findings from interpretation. It is not a diagnosis, treatment recommendation, product-safety determination or occupational clearance.

← Back to Doctor's Notes